Navigation Links
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
Date:6/3/2008

ly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

Safe Harbor Statement

This press release contains forward-looking statements including without limitation statements related to the future development and timing of late-stage trials of voreloxin (formerly SNS-595) and potential safety and efficacy and commercial potential of voreloxin. Words such as "promising," "advance," "look forward," "expects" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that Sunesis' drug development activities or those of its partners, including enrollment and reporting of results, could be halted significantly or delayed for various reasons; the risk that Sunesis' clinical trials for voreloxin or its other programs may not demonstrate safety or efficacy or lead to regulatory approval; the risk that preliminary data and trends may not be predictive of future data or results; the risk that Sunesis' preclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies; risks related to the conduct of Sunesis' clinical trials and manufacturing; and risks related to Sunesis' need for additional funding. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Annual Report on Form 10-K for the year ended December 31, 2007, Sunesis' Quarterly Report on Fo
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014 Proove Biosciences ... will be presenting research on the association between specific ... U.S. Psychiatric and Mental Health Congress’ 27th ... conference focuses on the theme of ‘Embracing Change.’ Mental ... a changing landscape. From the challenges presented by the ...
(Date:9/23/2014)... Manassas, VA (PRWEB) September 23, 2014 ... organization, is pleased to announce two important appointments to ... as Executive Vice President of Strategy and Technology and ... Director for the Standards Resource Center. Both roles are ... Raymond H. Cypess, President and CEO at ATCC described ...
(Date:9/23/2014)... and ANNAPOLIS JUNCTION, MD (PRWEB) September 23, 2014 ... research leader in personalized medicine, presented industry leading research ... misuse this past weekend at the American Academy ... The meeting took place in Phoenix, Arizona at the ... study on the linkage between gender and genetic predisposition ...
(Date:9/23/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced three ... to $5 million. The orders are all odour control projects ... continue to see new orders coming in," said Peter ... has climbed to over $11 million." About ... company that designs, manufactures and distributes a comprehensive line of ...
Breaking Biology Technology:Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 2Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting 3
... Pennsylvania and REHOVOT Israel, January 16, Rosetta ... today unveiled initial data relating to the ... which is,based on a simple blood draw, ... year. The,company,s scientists and collaborators have identified ...
... Varian, Inc.,(NasdaqGS: VARI) today announced a plan to ... to close certain facilities. , ... economic environment,we are taking proactive steps to reduce our ... while continuing to invest in new product,development and maintaining ...
... cells, vastly improved medical imaging techniques and lighter ... potential applications envisioned for organic electronics. ... Elisabetta Collini of University of Toronto,s Department of ... to new insights into the way molecules absorb ...
Cached Biology Technology:Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 2Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 3Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum 4Varian, Inc. Announces Cost Reduction Plan 2U of T chemistry discovery brings organic solar cells a step closer 2
(Date:9/23/2014)... Ill. Scientists have scoured cow rumens and termite ... cell walls for the production of next-generation biofuels, but ... in the human lower intestine, researchers report. , Their ... the National Academy of Sciences , is the first ... microbes in the human gut can digest fiber, breaking ...
(Date:9/23/2014)... essential in the development of animals and plants. The ... information be translated in a reliable manner to give ... French-flag model of stripe formation is a classic paradigm ... colours of the French flag, is caused by a ... middle or low concentrations of the morphogen a "blue", ...
(Date:9/23/2014)... Sept. 23, 2014 Research and Markets ... Market Forecast and Opportunities, 2019" report to their ... used for enhancing security and protection in private as ... . The country,s government is focusing on using biometric ... and other national IDs that are of crucial importance ...
Breaking Biology News(10 mins):Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3Recreating the stripe patterns found in animals by engineering synthetic gene networks 2India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3
... discovered the critical sequence of events by which insulin ... The study, appearing in the May 9 Journal of ... Institute of Child Health and Human Development and the ... , “This finding provides useful information for understanding disorders ...
... lipid membrane. The membrane is studded with many hundreds ... into and out of the cell. Such membrane proteins ... and make the nervous system work. Scientists at Stockholm ... membrane proteins in the enteric bacterium Escherichia coli. Their ...
... to migrate to the appropriate locations in the brain and ... in an intricate network. Growth cones, structures in the tips ... right direction, guided by a complex set of signals from ... axons to extend and grow in a particular direction; others ...
Cached Biology News:NIH Researchers Discover How Insulin Allows Entry of Glucose Into Cells 2Cerebral navigation: How do nerve fibers know what direction to grow in? 2
... Tray (3 per pack), 1. ... blot processing.Automated staining of Coomassie Blue ... nucleic acid analysis.Prepares blots for high ... control of protocol, solution, volume, and ...
... 1 g. High quality kits ... preparation that give consistent and ... and tissues.Clean up samples from ... Accurately quantitate protein for first-dimension ...
GOAT ANTI CARICA PAPAYA PAPAIN...
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
Biology Products: